Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 May 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 9 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is C and Author is de Vries, F.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
R. Williams, van Staa, T. P., Gallagher, A. M., Hammad, T., Leufkens, H. G. M., and de Vries, F., Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study, BMJ Open, vol. 8, p. e020827, 2018.
A. But, De Bruin, M. L., Bazelier, M. T., Hjellvik, V., Andersen, M., Auvinen, A., Starup-Linde, J., Schmidt, M. K., Furu, K., de Vries, F., Karlstad, O., Ekstrom, N., and Haukka, J., Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study, Diabetologia, vol. 60, pp. 1691-1703, 2017.
R. Williams, de Vries, F., Kothny, W., Serban, C., Lopez-Leon, S., Chu, C., and Schlienger, R., Cardiovascular safety of vildagliptin in patients with type 2 diabetes: A European multi-database, non-interventional post-authorization safety study, Diabetes Obes Metab, vol. 19, pp. 1473-1478, 2017.
A. Lalmohamed, Bazelier, M. T., van Staa, T. P., Uitdehaag, B. M., Leufkens, H. G., de Boer, A., and de Vries, F., Causes of death in patients with multiple sclerosis and matched referent subjects: a population-based cohort study, Eur J Neurol, vol. 19, pp. 1007-14, 2012.
den C. Heijer, Hoebe, C., Driessen, J. H., Wolffs, P., van den Broek, I., Hoenderboom, B., Williams, R., de Vries, F., and Dukers-Muijrers, N., Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease, Ectopic Pregnancy, and Female Infertility: A Retrospective Cohort Study Among Primary Care Patients, Clinical Infectious Diseases, 2019.
R. G. de Jong, Gallagher, A. M., Herrett, E., Masclee, A. A., Janssen-Heijnen, M. L., and de Vries, F., Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1460-1464, 2016.
F. de Vries, Setakis, E., and van Staa, T. P., Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes, Br J Clin Pharmacol, vol. 70, pp. 429-38, 2010.
S. Abtahi, Driessen, J. H. M., Burden, A. M., Souverein, P. C., van den Bergh, J. P., van Staa, T. P., Boonen, A., and de Vries, F., Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study, Ann Rheum Dis, 2020.
O. A. Oshagbemi, Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., de Boer, A., and de Vries, F., C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD, Pulm Pharmacol Ther, p. 101870, 2019.
[Page last reviewed 4 May 2021]